Kevin L McLaren

Title: Kevin L McLaren: Innovator in Anti-Inflammatory Compounds

Introduction

Kevin L McLaren is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. With a total of 3 patents to his name, McLaren's work has the potential to impact therapeutic practices significantly.

Latest Patents

One of McLaren's latest patents focuses on quinoline derivatives as anti-inflammatory agents. This invention relates to compounds that are generally anti-inflammatory and analgesic, represented by a specific formula. The compounds include various substituents and can exist as prodrugs, individual isomers, mixtures of isomers, and pharmaceutically acceptable salts. The invention also encompasses pharmaceutical compositions containing these compounds and methods for their therapeutic use.

Career Highlights

Throughout his career, McLaren has worked with prominent companies in the pharmaceutical industry, including Syntex Inc. and Roche Palo Alto LLC. His experience in these organizations has contributed to his expertise in developing innovative compounds.

Collaborations

Some of McLaren's notable coworkers include David Bernard Smith and Chris Allen Broka. Their collaboration has likely fostered an environment of innovation and creativity in their respective projects.

Conclusion

Kevin L McLaren is a distinguished inventor whose work in anti-inflammatory compounds showcases his commitment to advancing pharmaceutical science. His contributions are poised to make a lasting impact in the field of medicine.